RhumbLine Advisers’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.49M Sell
434,352
-5,999
-1% -$34.4K ﹤0.01% 1771
2025
Q1
$3.59M Buy
440,351
+28,383
+7% +$232K ﹤0.01% 1520
2024
Q4
$3.88M Sell
411,968
-138
-0% -$1.3K ﹤0.01% 1545
2024
Q3
$4.4M Sell
412,106
-22,506
-5% -$240K ﹤0.01% 1495
2024
Q2
$4.31M Buy
434,612
+19,491
+5% +$193K ﹤0.01% 1475
2024
Q1
$4.89M Buy
415,121
+12,481
+3% +$147K ﹤0.01% 1433
2023
Q4
$5.71M Sell
402,640
-13,480
-3% -$191K 0.01% 1335
2023
Q3
$5.06M Buy
416,120
+1,372
+0.3% +$16.7K 0.01% 1335
2023
Q2
$5.21M Sell
414,748
-12,588
-3% -$158K 0.01% 1352
2023
Q1
$4.74M Buy
427,336
+33,941
+9% +$376K 0.01% 1351
2022
Q4
$4.8M Buy
393,395
+20,970
+6% +$256K 0.01% 1300
2022
Q3
$3.89M Buy
372,425
+33,645
+10% +$351K 0.01% 1377
2022
Q2
$3.64M Buy
338,780
+52,874
+18% +$568K 0.01% 1438
2022
Q1
$2.71M Sell
285,906
-26,692
-9% -$253K ﹤0.01% 1658
2021
Q4
$3.61M Sell
312,598
-3,683
-1% -$42.5K ﹤0.01% 1555
2021
Q3
$3.02M Buy
316,281
+7,018
+2% +$67K ﹤0.01% 1658
2021
Q2
$2.98M Buy
309,263
+2,436
+0.8% +$23.5K ﹤0.01% 1733
2021
Q1
$3.03M Sell
306,827
-31,780
-9% -$314K ﹤0.01% 1696
2020
Q4
$7.82M Buy
338,607
+3,773
+1% +$87.1K 0.01% 1084
2020
Q3
$4.73M Sell
334,834
-76,062
-19% -$1.07M 0.01% 1206
2020
Q2
$6.2M Buy
410,896
+38,709
+10% +$584K 0.01% 1072
2020
Q1
$3.44M Buy
372,187
+15,150
+4% +$140K 0.01% 1243
2019
Q4
$3.48M Buy
357,037
+17,371
+5% +$169K 0.01% 1482
2019
Q3
$2.72M Buy
339,666
+19,791
+6% +$159K 0.01% 1559
2019
Q2
$3.99M Buy
319,875
+64,532
+25% +$805K 0.01% 1325
2019
Q1
$3.47M Buy
255,343
+2,989
+1% +$40.7K 0.01% 1382
2018
Q4
$2.42M Buy
252,354
+81,792
+48% +$784K 0.01% 1529
2018
Q3
$2.06M Sell
170,562
-13,250
-7% -$160K ﹤0.01% 1642
2018
Q2
$2.87M Buy
183,812
+10,306
+6% +$161K 0.01% 1473
2018
Q1
$2.61M Buy
173,506
+15,275
+10% +$230K 0.01% 1459
2017
Q4
$2.28M Buy
158,231
+1,350
+0.9% +$19.4K ﹤0.01% 1554
2017
Q3
$2.37M Buy
156,881
+18,443
+13% +$278K 0.01% 1511
2017
Q2
$1.39M Buy
138,438
+2,690
+2% +$27.1K ﹤0.01% 1774
2017
Q1
$968K Buy
135,748
+4,958
+4% +$35.4K ﹤0.01% 1935
2016
Q4
$650K Buy
130,790
+11,646
+10% +$57.9K ﹤0.01% 2093
2016
Q3
$882K Buy
119,144
+11,856
+11% +$87.8K ﹤0.01% 1888
2016
Q2
$586K Buy
107,288
+12,170
+13% +$66.5K ﹤0.01% 2098
2016
Q1
$804K Buy
95,118
+1,170
+1% +$9.89K ﹤0.01% 1936
2015
Q4
$911K Sell
93,948
-9,180
-9% -$89K ﹤0.01% 1870
2015
Q3
$1.44M Buy
103,128
+21,613
+27% +$302K ﹤0.01% 1544
2015
Q2
$1.15M Buy
+81,515
New +$1.15M ﹤0.01% 1780
2014
Q2
Sell
-27,686
Closed -$57K 3027
2014
Q1
$57K Sell
27,686
-1,020
-4% -$2.1K ﹤0.01% 2960
2013
Q4
$67K Hold
28,706
﹤0.01% 2988
2013
Q3
$67K Sell
28,706
-267
-0.9% -$623 ﹤0.01% 2958
2013
Q2
$68K Buy
+28,973
New +$68K ﹤0.01% 3285